chr19-18173940-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006332.5(IFI30):āc.99C>Gā(p.Asp33Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000357 in 1,399,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006332.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFI30 | NM_006332.5 | c.99C>G | p.Asp33Glu | missense_variant | 1/7 | ENST00000407280.4 | NP_006323.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFI30 | ENST00000407280.4 | c.99C>G | p.Asp33Glu | missense_variant | 1/7 | 1 | NM_006332.5 | ENSP00000384886.1 | ||
ENSG00000268173 | ENST00000593731.1 | n.*1535C>G | non_coding_transcript_exon_variant | 19/25 | 2 | ENSP00000471914.1 | ||||
ENSG00000268173 | ENST00000593731.1 | n.*1535C>G | 3_prime_UTR_variant | 19/25 | 2 | ENSP00000471914.1 | ||||
IFI30 | ENST00000597802.2 | c.99C>G | p.Asp33Glu | missense_variant | 2/3 | 3 | ENSP00000470527.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000357 AC: 5AN: 1399200Hom.: 0 Cov.: 32 AF XY: 0.00000435 AC XY: 3AN XY: 690214
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 30, 2024 | The c.99C>G (p.D33E) alteration is located in exon 1 (coding exon 1) of the IFI30 gene. This alteration results from a C to G substitution at nucleotide position 99, causing the aspartic acid (D) at amino acid position 33 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at